Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiko Tanaka

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|May 20, 2009
The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100Tsutomu Murakami, Sei Kumakura, Toru Yamazaki, et al.
The Journal of Infectious Diseases|August 27, 2002
Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected personsKieran R Daly, Carl J Fichtenbaum, Reiko Tanaka, et al.
Medical Mycology Journal|November 30, 2011
Genotypes of Candida albicans involved in development of candidiasis and their distribution in oral cavity of non-candidiasis individualsYuki Takagi, Hisao Hattori, Hidesada Adachi, et al.
Environmental Research|January 21, 2015
Gaseous chemical compounds in indoor and outdoor air of 602 houses throughout Japan in winter and summerShigehisa Uchiyama, Takuya Tomizawa, Asumo Tokoro, et al.
Viruses|April 23, 2022
Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell LeukemiaMegumi Kato, Naoki Imaizumi, Reiko Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2003
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activityKozi Ichiyama, Sei Yokoyama-Kumakura, Yuetsu Tanaka, et al.
Pathology International|January 20, 2015
Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndromeYasuhiro Iribe, Naoto Kuroda, Yoji Nagashima, et al.
Familial Cancer|July 16, 2020
Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case reportYasuhiro Iribe, Mitsuko Furuya, Yousuke Shibata, et al.
Plos One|March 15, 2016
Pulmonary Neoplasms in Patients with Birt-Hogg-Dubé Syndrome: Histopathological Features and Genetic and Somatic EventsMitsuko Furuya, Reiko Tanaka, Koji Okudela, et al.
Frontiers in Microbiology|March 7, 2017
Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese IndividualsDaisuke Motooka, Kosuke Fujimoto, Reiko Tanaka, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|May 20, 2009
The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100Tsutomu Murakami, Sei Kumakura, Toru Yamazaki, et al.
The Journal of Infectious Diseases|August 27, 2002
Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected personsKieran R Daly, Carl J Fichtenbaum, Reiko Tanaka, et al.
Medical Mycology Journal|November 30, 2011
Genotypes of Candida albicans involved in development of candidiasis and their distribution in oral cavity of non-candidiasis individualsYuki Takagi, Hisao Hattori, Hidesada Adachi, et al.
Environmental Research|January 21, 2015
Gaseous chemical compounds in indoor and outdoor air of 602 houses throughout Japan in winter and summerShigehisa Uchiyama, Takuya Tomizawa, Asumo Tokoro, et al.
Viruses|April 23, 2022
Elevation of the Plasma Levels of TNF Receptor 2 in Association with Those of CD25, OX40, and IL-10 and HTLV-1 Proviral Load in Acute Adult T-Cell LeukemiaMegumi Kato, Naoki Imaizumi, Reiko Tanaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2003
A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activityKozi Ichiyama, Sei Yokoyama-Kumakura, Yuetsu Tanaka, et al.
Pathology International|January 20, 2015
Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndromeYasuhiro Iribe, Naoto Kuroda, Yoji Nagashima, et al.
Familial Cancer|July 16, 2020
Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case reportYasuhiro Iribe, Mitsuko Furuya, Yousuke Shibata, et al.
Plos One|March 15, 2016
Pulmonary Neoplasms in Patients with Birt-Hogg-Dubé Syndrome: Histopathological Features and Genetic and Somatic EventsMitsuko Furuya, Reiko Tanaka, Koji Okudela, et al.
Frontiers in Microbiology|March 7, 2017
Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese IndividualsDaisuke Motooka, Kosuke Fujimoto, Reiko Tanaka, et al.
Pageof 21